Purchase Order HHSN2682006MJ613006P

<p>This is a definitive contract awarded by the National Cancer Institute, a civilian agency, to the National Public Health Institute in Finland. The contract is for the follow-up of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study cohort, with a ceiling value of $11,647,439.31 and a completion date of November 30, 2009. The contract was awarded on March 15, 2003 and does not have a set-aside designation.</p>

Westat, Inc. was awarded a definitive cost-plus-fixed-fee prime contract by the National Institutes of Health National Cancer Institute valued at up to four hundred thirteen million, six hundred twenty-five thousand, four hundred thirty-four dollars and eighty-eight cents ($413,625,434.88) to serve as the Study Coordinating and Data Management Center for the TAS::75 0849::TAS PROSTATE, LUNG, COLORECTAL, AND OVARIAN CANCER SCREENING TRIAL from September 30, 1992 through September 29, 2015. The...

This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) to Westat, Inc., a for-profit provider of professional services to government agencies. The $199,488.00 firm fixed-price contract is a call under the Achieving Public Health Impact Through Research (APHITR) blanket purchase agreement (BPA). The contract supports the APHIR PROSTATE CANCER program, with work to be performed in Potomac, Maryland. Westat has a track record of...

This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the Connecticut Department of Public Health's Business Office Division. The contract is for a &quot;Patterns of Care/Quality of Care Study: Diagnosis Year 2014 (SEER)&quot; with a potential value of $49,084.00 and a completion date of August 14, 2016. The contract supports the Surveillance, Epidemiology, and End Results (SEER)...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, for the NCI Patterns of Care Study focused on prostate cancer, ovarian cancer, and small intestine cancer diagnosed in 2021. The $104,718 contract runs from May 1, 2024 through April 30, 2025 and does not have a set-aside designation. The study aims to describe the...

<p>This is a definitive federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Mansfield Medical Research on September 15, 1992. The contract has a ceiling value of $443,137,907.91 and is for the PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL. The contract is a cost-sharing agreement and does not have a set-aside designation. The contract is scheduled to be completed by March 31, 2012. The place of performance is Marshfield, Wisconsin.</p>

This is a $97,457 firm-fixed price purchase order awarded by the National Cancer Institute (NCI) to the Department of Public Health Connecticut for the NCI Patterns of Care Study focused on diagnosis year 2020 breast and colorectal cancer cases. The study aims to collect data on biomarker testing, targeted therapies, adjuvant treatments, and the impact of the COVID-19 pandemic on cancer screening, diagnosis, treatment, and supportive/palliative care. It involves a stratified random sample of...

The Centers for Disease Control and Prevention (CDC) awarded a $377,278 firm fixed price contract to Fred Hutchinson Cancer Center, doing business as Seattle Cancer Care Alliance (SCCA), to conduct consultation and cancer research services. SCCA will perform comparative modeling through its Cancer Intervention and Surveillance Modeling Network (CISNET) prostate cancer working group to analyze potential outcomes if Gleason score 6 prostate cancer were reclassified as a non-cancer diagnosis. The...

This federal contract award supports a research study examining the relationship between radiation dose-response and the development of secondary primary cancers, specifically focusing on stomach, esophagus, and pancreatic cancers among cancer survivors. The project, valued at $282,418, operates under a definitive cost-no-fee contract structure, with performance taking place in Denmark. The award was executed on September 30, 2003, with an ultimate completion date of September 29, 2005. No...

This federal contract was awarded by the National Cancer Institute (NCI) to Westat, Inc., a for-profit professional services firm headquartered in Rockville, Maryland. The $4,807,754.92 cost-plus-fixed-fee contract is for a Central Data Collection Center (CDCC) to support various NCI cancer screening trials, including the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and the National Lung Screening Trial (NLST). The contract does not have a set-aside designation. Westat...